JAK inhibitors: current position in treatment strategies for use in inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

JAK inhibitors: current position in treatment strategies for use in inflammatory bowel disease

Published:2020-12 Issue: Volume:55 Page:99-109
ISSN:1471-4892
Container-title:Current Opinion in Pharmacology
language:en
Short-container-title:Current Opinion in Pharmacology

Author:

Hernandez-Rocha Cristian^ORCID,Vande Casteele Niels^ORCID

Funder

R-Biopharm

Takeda

UCB

Alimentiv, Inc.

Celltrion

Prometheus

Canadian Institutes of Health Research

Canadian Association of Gastroenterology

American Gastroenterological Association

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference69 articles.

1. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults;Lamb;Gut,2019

2. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Alatab;Lancet Gastroenterol Hepatol,2020

3. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-Part I;Knowles;Inflamm Bowel Dis,2018

4. Cytokine networks in the pathophysiology of inflammatory bowel disease;Friedrich;Immunity,2019

5. Cortisone in ulcerative colitis; final report on a therapeutic trial;Truelove;Br Med J,1955

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors;Cell Communication and Signaling;2024-01-25

2. Taurodeoxycholate ameliorates DSS-induced colitis in mice;International Immunopharmacology;2023-09

3. Cervical lymphadenitis caused by Mycobacterium avium in a patient treated with Janus kinase inhibitors;International Journal of Infectious Diseases;2023-08

4. Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review;Frontiers in Pharmacology;2023-03-20

5. JAK-Inhibitoren: eine neue Therapieoption;Gastro-News;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3